PROGNOSIS OF DISABILITY IN RELAPSING-REMITTING MULTIPLE SCLEROSIS

被引:0
|
作者
Somilo, O., V [1 ]
Kalbus, O., I [1 ]
Makarov, S. O. [1 ]
Sorokin, A. V. [1 ]
Shastun, N. P. [1 ]
机构
[1] Dnipro State Med Univ, Dnipro, Ukraine
来源
WORLD OF MEDICINE AND BIOLOGY | 2023年 / 84卷 / 02期
关键词
multiple sclerosis; atrophy; disability; prognosis; course;
D O I
10.26724/2079-8334-2023-2-84-147-152
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
105 patients with relapsing-remitting multiple sclerosis aged 18 to 49 were examined. The degree of disability was assessed using the Expanded Disability Status Scale. Neuropsychological examination was performed to determine the level of personal and reactive anxiety on the Spielberger-Khanin scale and depression on the Beck scale. Magnetic resonance imaging of the brain was performed and brain atrophy indices were calculated, namely, the bicaudal and Sylvian sulcus indices. The ability of the studied clinical and paraclinical indicators to predict the progression of disability in multiple sclerosis was assessed using ROC analysis. Areas under the ROC curve had excellent prognostic characteristics for indices of atrophy, levels of anxiety and depression about significant neurological manifestations (EDSS & GE;3.5 points) and disability in patients with relapsing-remitting multiple sclerosis. According to the data of the multiple logistic regression analysis, it was established that the degree of subcortical atrophy according to the BCR index is a statistically significant independent factor affecting the appearance of significant neurological manifestations, according to the adjusted odds ratio, purified from the influence of other factors (OR=26.2; 95 % CI 3.5-198.3), the level of depression on the BDI scale (OR=97.2; 95 % CI (3.4-2744.0). A significant protective effect of disease-modifying therapy was confirmed (OR=0.006; 95 % CI 0.001-0.045).
引用
收藏
页码:147 / 152
页数:6
相关论文
共 50 条
  • [1] Disability trajectories in relapsing-remitting multiple sclerosis
    Uher, T.
    Horakova, D.
    Havrdova, E. Kubala
    Izquierdo, G.
    Eichau, S.
    Patti, F.
    Prat, A. P.
    Girard, M.
    Duquette, P.
    Grammond, P.
    Onofrj, M.
    Lugaresi, A. L.
    Bergamaschi, R.
    Ozakbas, S.
    Grand'Maison, F.
    Hupperts, R.
    Sola, P.
    Ferraro, D.
    Sa, M. J.
    Kalincik, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 813 - 814
  • [2] Parity and disability progression in relapsing-remitting multiple sclerosis
    Achiron, Anat
    Ben-David, Alon
    Gurevich, Michael
    Magalashvili, David
    Menascu, Shay
    Dolev, Mark
    Stern, Yael
    Ziv-Baran, Tomer
    [J]. JOURNAL OF NEUROLOGY, 2020, 267 (12) : 3753 - 3762
  • [3] Relapsing-remitting multiple sclerosis
    Flores, A
    Ochoa, E
    Zamora, S
    Barrientos, UN
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 214 (1-2) : 110 - 110
  • [4] Disability Progression in a Clinical Trial of Relapsing-Remitting Multiple Sclerosis
    Rudick, Richard A.
    Lee, Jar-Chi
    Cutter, Gary R.
    Miller, Deborah M.
    Bourdette, Dennis
    Weinstock-Guttman, Bianca
    Hyde, Robert
    Zhang, Hao
    You, Xiaojun
    [J]. ARCHIVES OF NEUROLOGY, 2010, 67 (11) : 1329 - 1335
  • [5] Relapses and subsequent worsening of disability in relapsing-remitting multiple sclerosis
    Young, P. J.
    Lederer, C.
    Eder, K.
    Daumer, M.
    Neiss, A.
    Polman, C.
    Kappos, L.
    [J]. NEUROLOGY, 2006, 67 (05) : 804 - 808
  • [6] Short-term prognosis in relapsing-remitting multiple sclerosis
    Diaz-Sanchez, M.
    Alvarez-Cermeno, J. C.
    Garcia-Barragan, N.
    Sadaba, M. C.
    Masjuan, J.
    Espino, M.
    Gomez-Rial, J.
    Gonzalez-Porque, P.
    Muriel, A.
    Villar, L. M.
    [J]. MULTIPLE SCLEROSIS, 2006, 12 : S89 - S89
  • [7] Interferon Beta Use and Disability Prevention in Relapsing-Remitting Multiple Sclerosis
    Greenberg, Benjamin M.
    Balcer, Laura
    Calabresi, Peter A.
    Cree, Bruce
    Cross, Anne
    Frohman, Teresa
    Gold, Ralf
    Havrdova, Eva
    Hemmer, Bernhard
    Kieseier, Bernd C.
    Lisak, Robert
    Miller, Aaron
    Racke, Michael K.
    Steinman, Lawrence
    Stuve, Olaf
    Wiendl, Heinz
    Frohman, Elliot
    [J]. JAMA NEUROLOGY, 2013, 70 (02) : 248 - 251
  • [8] No evidence for CCVSI in relapsing-remitting multiple sclerosis patients with moderate disability
    Martin Juenemann
    Mesut Yeniguen
    Erwin Stolz
    Martin Berghoff
    [J]. Journal of Neurology, 2013, 260 : 2409 - 2410
  • [9] Rituximab for relapsing-remitting multiple sclerosis
    He, Dian
    Guo, Rui
    Zhang, Fubo
    Zhang, Chao
    Dong, Shuai
    Zhou, Hongyu
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
  • [10] Autohemotherapy for relapsing-remitting multiple sclerosis
    Mubaidin, AF
    Horani, KA
    Dehayyat, MA
    Shehab, M
    Abu-Ruman, IA
    Shurbaji, AA
    Kurdi, A
    Hiari, M
    Khakish, M
    Harahsheh, O
    Dabbas, M
    [J]. NEUROLOGY, 2001, 56 (08) : A75 - A75